Genmab — December 2023
-
-
For os her på PI har Genmab vel været en no-brainer i laang tid så godt at se det også er ved at gå op for nogle af analytikerne. Der har jo i bund og grund ikke været dårligt nyt fra Genmab efter kursen var 3300 og alle analytikerne havde targets over 3000. Den eneste FA ændring er vel den høje rente.
-
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody
CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL) -
or as Abbvie states "This data may support investigating optimized step-up dose in an outpatient setting." https://news.abbvie.com/2023-12-09-New-Data-for-Bispecific-Antibody-Epcoritamab-DuoBody-R-CD3xCD20-Shows-Strong,-Durable-Treatment-Response-for-Patients-with-Difficult-To-Treat-Relapsed-Refractory-R-R-Follicular-Lymphoma-FL?utm_campaign=generic&utm_medium=social&utm_source=TW&utm_content=other&sf270770143=1
-
Godmorgen
-
Breaking new ground in #MultipleMyeloma #research!
@DrOlaLandgren
shares the analysis of the Phase 2 Centaurus Study, shedding light on the efficacy and safety of daratumumab monotherapy in patients with intermediate-risk or high-risk smoldering multiple #myeloma. #ASH23 https://twitter.com/SylvesterCancer/status/1733635907226391029 https://twitter.com/theMMRF/status/1733633272096469063 https://twitter.com/MM_Hub/status/1733651336317620661 -
-
"This real world analysis is important since 80% of these pts wouldn’t have been eligible for the MagesTEC-1 trial" https://twitter.com/Curley_MD/status/1733548449336107277
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind